AWHP recently submitted comments to a Request for Information from the FDA asking the public to share their perspectives on how to increase access to nonprescription drugs.

AWHP urged Senate Leadership to include the Sewell Act (S.339) in the final year-end healthcare package.

AWHP urged House Leadership to include the Sewell Act (H.R.842) in the final year-end healthcare package.

AWHP provided comment ahead of a public workshop on the use of pharmacotherapy to address obesity among Nevada Medicaid beneficiaries.

AWHP urged members of the New Hampshire Senate Health and Human Services Committee to reconsider the decision to end Medicaid coverage of obesity management medications when prescribed solely for weight loss.

AWHP urged members of the New Hampshire House of Representatives Health, Human Services and Elderly Affairs Committee to reconsider the decision to end Medicaid coverage of obesity management medications when prescribed solely for weight loss.

AWHP urged New Hampshire Governor Kelly Ayotte to reconsider the decision to end Medicaid coverage of obesity management medications when prescribed solely for weight loss.

AWHP submitted comments to the CDC’s ACIP ahead of its December 2025 meeting urging the importance of evidence-based vaccine science, of the hepatitis B vaccine for newborns, and the continued recommendation of combination vaccines.

AWHP submitted comments to the HRSA-supported Women’s Preventive Services Initiative (WPSI) on their Draft Cervical Cancer Screening Recommendations.